B · Normal
On September 11th, GenScript Biotechnology announced on the Hong Kong Stock Exchange that it would place new shares under the general authorization at a price of HK$30.50 per share.
Related telegraphs
On September 22, Xiaomi Group spent HK$48.9 million to repurchase 1.8 million Cl
09-22 18:48
[Meituan: Add 30 billion yuan to invest in instant retail in the next three year
09-22 17:33
On September 22, information from the Hong Kong Stock Exchange showed that JPMor
09-22 17:06
On September 22, Hong Kong Stock Exchange information showed that BlackRock’s sh
09-22 17:04
On September 22, Hong Kong Exchange information showed that BlackRock’s sharehol
09-22 17:04
On September 22, information from the Hong Kong Stock Exchange showed that JPMor
09-22 17:03
Comments